Regulations.gov document
Acknowledgment Letter from FDA DMB to Novitium Pharma, LLC
Other · FDA-2024-P-5469 · posted Nov 22, 2024
Key facts
| Document ID | FDA-2024-P-5469-0002 |
|---|---|
| Title | Acknowledgment Letter from FDA DMB to Novitium Pharma, LLC |
| Document type | Other |
| Subtype | Acknowledgement Letter/Receipt |
| Agency | FDA |
| Docket | FDA-2024-P-5469 |
| Posted | Nov 22, 2024 |
| Comment period opens | Nov 22, 2024 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: